11d
Zacks Investment Research on MSNPSTV Stock Skyrockets on FDA's Orphan Drug Tag for Cancer TherapyShares of Plus Therapeutics, Inc. PSTV were up a whopping 311.4% on March 6 after the company announced that the FDA has ...
Rhenium and technetium not only share the same group in the periodic table, but also have some common history relating to how they were — or indeed weren't — discovered. Eric Scerri explains ...
Basically, these films are very good at capturing these single charge ions ... materials recycling and metal recovery. For example, rhenium is both a valuable metal used as a catalyst and ...
AUSTIN, Texas, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company” or “Plus Therapeutics”), a clinical-stage ...
This support is particularly significant given the $4.3 million Prescription Drug User Fee Act charge in 2025. Plus Therapeutics has recently completed a Phase 1 single-dose trial for Rhenium ...
The ReSPECT-LM single-dose escalation trial assessed the safety, tolerability, and potential efficacy of intrathecally administered Rhenium (186 Re) Obisbemeda in patients with leptomeningeal ...
This support is particularly significant given the $4.3 million Prescription Drug User Fee Act charge in 2025. Plus Therapeutics has recently completed a Phase 1 single-dose trial for Rhenium (186Re) ...
A novel injectable radiotherapy, rhenium (186Re) obisbemeda is specifically developed to deliver highly targeted high-dose radiation in central nervous system (“CNS”) tumors, with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results